The ranking for this scope covers 78 companies, with the leading assignee holding 25 of the 254 records and the ten leading assignees together holding 52.8%. That group mixes established aerospace life-support suppliers with medical-device and industrial-gas names, reflecting that chemical oxygen generation and mask delivery hardware are used in both civil aviation and clinical settings. Outside the top ten the ranking has a long tail of single- or few-filing entrants, so the field is concentrated at the top but not closed to new filers in adjacent niches.

Filing peaked at 19 records in 2019 and has declined since, with the 2021-to-2024 span down 63% from 16 to 6 annual filings. That is a real slowdown over a period long enough to be considered complete, but publication lag of roughly 18 months means 2025 and 2026 counts are still filling in and should not yet be read as confirmation of a continued decline. A reassessment in six to twelve months will give a clearer read on whether the trend has stabilised or continued downward.

US4536370A, assigned to Dragerwerk, covers a chemical oxygen generator that pairs an ignitable oxygen candle with a surrounding pressure space pre-filled with compressed oxygen, released via an actuated member when the starting means fires. The design solves the multi-second delay between candle ignition and substantial oxygen output by supplying stored compressed oxygen immediately on activation. Anyone designing a generator that combines a chemical candle with an immediate-release compressed-oxygen reservoir triggered by the same starting mechanism should review this claim scope closely, since it sits at the core of how instant-response chemical oxygen systems are typically engineered.

Relative to the two dominant classes — A62B rescue equipment at 51.2% of records and C01B inorganic chemistry at 37.0% — categories such as C06D gas-generating compositions (6.3%), A62D chemical protection and detox (5.1%), and B01D separation processes (7.5%) show markedly lower filing density. That does not guarantee open claim space, since low counts can also reflect a narrower true technology base, but it flags areas worth a closer freedom-to-operate check before assuming the space is crowded. Portable oxygen concentrator flow control and breathing demand regulator sensing are two specific sub-areas within these lower-density classes worth individual review.

Collaboration is limited: this scope identifies only 10 co-assignee pairs, with the strongest recurring pairs sharing between two and four co-filed records, mostly clustered around portable oxygen concentrator development. Most of the 78 ranked assignees file independently rather than through joint ventures or shared research agreements. This suggests that competitive positioning in this field is built through in-house R&D and acquisition of smaller specialist filers rather than through formal patent-pooling arrangements.